Platelets play an important role in atherothrombotic disease. The currently available antiplatelet drugs target key steps of platelet activation including thromboxane A 2 synthesis, ADP-mediated ...

The cyclooxygenase-2 inhibitors are not antiplatelet drugs. [2] In 1998 only one drug in this class was available, a monoclonal antibody (abciximab) directed against the fibrinogen receptor on the ...

Two common medications that are categorized as blood thinners and used to prevent blood clots are anticoagulants and antiplatelets. Both are essential in treating conditions caused by blood clots ...

Ongoing studies of prasugrel should help determine whether this drug has a role in the initial ... any data on alternative antiplatelet strategies in ACS would need to be compelling.

Researchers believe that omega-3 has an antithrombotic effect, so taking it with anticoagulant or antiplatelet drugs can lead to an increased risk of bleeding. Along with that, research also suggests ...

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.